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Background: Idiopathic epilepsies and epileptic syndromes predominate childhood and adolescence epilepsy. The
aim of the present study was to investigate the clinical course and outcome of idiopathic childhood epilepsy and
identify variables determining both early and long-term prognosis.
Methods: We followed 303 children with newly diagnosed idiopathic epilepsy aged 1–14 years old, both
prospectively and retrospectively. Outcome was defined at one, 2 and 4 years of follow-up, as well as at the end of
the study period for all patients. Based on the data collected, patients were classified in four patterns of clinical
course: “excellent”, “improving”, “relapsing” and “poor”. Variables defined at intake and after the initial year of
treatment were analyzed for their prognostic relevance towards the clinical course and outcome of the patients.
Results: The mean age at seizure onset was 6,7 years and the mean duration of follow-up was 8,3 years (range
2,0-22,0,SD 4,24). During the initial year of treatment, 70,3% of patients were seizure-free. The course of epilepsy was
“excellent” in 53,1% of the subjects, “improving” in 22,8%, “relapsing” in 22,1% whereas only 6 children with
idiopathic epilepsy (2%) had a “poor” clinical course exhibiting drug-resistance. After multivariate analysis, variables
predictive of a poor initial response to therapy were early seizure onset, multiple seizure types and history of status
epilepticus. At the end of follow-up, early response to treatment was of significant positive predictive value, while
the presence of multiple seizure types and the history of migraine had a negative impact on prognosis.
Conclusions: In the vast majority of children, the long-term prognosis of idiopathic epilepsy is favorable. More than
half of the patients attain seizure freedom immediately and their clinical course is considered “excellent”. About one
fifth exhibit either an improving or a fluctuating course. Early seizure onset, multiple seizure types and status
epilepticus are predictive of an initial poor response to treatment in children with idiopathic epilepsy. Initial
non-response to treatment, multiple seizure types and history of migraine are determinants of a less favorable final
outcome after long-term follow-up.
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Epilepsy is one of the most common chronic neurologic
disorders diagnosed in children and adolescents, with an
estimated prevalence in Europe of 4,5-5 per 1000 [1].
The vast majority of epilepsies encountered under the
age of 15 years are idiopathic, developing without any
identifiable or suspected cause, other than a genetic pre-
disposition in many cases. A large number of children
with “epilepsy-only” are attended and followed-up even
by general paediatricians in everyday clinical practice.
Therefore, study of the clinical course and seizure out-
come of idiopathic epileptic syndromes and epilepsies is
of the utmost importance in the treatment of children
and adolescents with epilepsy.
It is broadly recognized that the individual prognosis
of epilepsy reflects primarily its underlying etiology and
syndromic classification. With respect to seizure control,
studies of the natural history of new-onset childhood
epilepsy indicate that epilepsies classified as idiopathic
have an overall good prognosis [2,3]. However, it has
been proven that the course of epilepsy and the outcome
regarding seizure occurrence, both at short-term obser-
vation and after many years of follow-up, vary consi-
derably, even among patients with the same epileptic
syndrome and determinants of the individual prognosis
among idiopathic childhood epilepsies remain largely
unknown. Most of the existing reports on the prognosis
of childhood epilepsy comprise cases of both idiopathic
and non-idiopathic aetiology, including subjects with
self-remitting benign epileptic syndromes and others
with drug resistant symptomatic epilepsies or epileptic
encephalopathies. In the present study we attempted to
investigate the clinical course and outcome in a homoge-
neous group of children and adolescents with idiopathic
epilepsy without any underlying etiology or major comor-
bidities, and to determine factors associated with a poor
response to therapy among this subgroup of epilepsies
with an overall favorable prognosis.
Methods
Patients
Children and adolescents under the age of 14 years old
who were diagnosed with idiopathic epilepsy before
December 31st 2010 were included in the study. Sub-
jects were identified on the basis of hospital and out-
patient epilepsy clinic records. All were prescribed AED
treatment and were followed-up until December 31, 2012.
Altogether, 303 eligible consecutive patients were iden-
tified, 47 first evaluated for epilepsy between January 1st
2008 and December 31st 2010 and followed-up pro-
spectively, and 256 diagnosed before January 2008 and
followed both retrospectively and prospectively. For the
retrospective group the diagnosis was based on suffi-
cient and detailed clinical and EEG documentation andreview of their entire records by a team of two child
neurologists. Subjects were excluded from the study
when matters of non-compliance to therapy were encoun-
tered, when episodes initially considered being epileptic
seizures proved to be of non-epileptic nature or when the
initial diagnosis of idiopathic aetiology was contradicted
by newer findings. All patients were reevaluated at the end
of the study follow-up, by December 31, 2012.
Treatment
Upon diagnosis, an appropriate antiepileptic drug (AED)
was chosen by a specialized child neurologist, taking into
account the seizure type, syndromic classification, side-
effect and interaction profiles. In principle, treatment was
commenced after two or more seizures, with a single drug
when possible. Patients were subsequently evaluated at the
epilepsy outpatient clinic. At every follow-up visit, clinical
information and the response to AED treatment were
recorded. Drug doses were adjusted as clinical circum-
stances and weight growth dictated and treatment was
altered to another drug if seizures continued using an
appropriate daily dose or if the patient developed a se-
vere adverse effect. A combination of drugs was used in
children whose epilepsy remained uncontrolled despite
treatment with two or three single drug regimens.
Study protocol
According to the study protocol, early response to treat-
ment during the initial 12 months was recorded for all
patients and the outcome regarding seizure control was
documented at two years of follow-up (short-term), at
four years of follow-up (long-term), as well as at the end
of data collection. For a minority of subjects who were en-
rolled to the study between January 1 2009 and December
31 2010, long-term outcome of seizure control could not
be documented as yet at the time of writing of the article.
The course of epilepsy was assessed by comparing the
initial 12 months, second year, fourth year and last year
of follow-up on the occurrence of seizures or not.
Definitions
Seizures and epileptic syndromes were classified ac-
cording to the guidelines of the International League
Against Epilepsy (ILAE) [4]. The syndromic classifica-
tion according to ILAE 1989 has been replaced by the
new proposed diagnostic scheme in the report of ILAE
task force on classification and terminology of 2006
[5,6]. Epilepsy and epileptic syndromes were classified
as idiopathic depending upon factors such as age at
seizure onset, type of seizures, electroencephalographic
changes, family history, absence of an anatomic brain
lesion or other neurological signs or symptoms and a
presumed genetic origin.
Dragoumi et al. BMC Neurology 2013, 13:206 Page 3 of 12
http://www.biomedcentral.com/1471-2377/13/206In this study, “early remission” was defined as seizure-
freedom achieved immediately or within the initial
3 months of treatment, whereas “initial non-response”
was defined as the occurrence of seizures beyond the
first 3 months of follow-up during the initial year of
treatment. Patients were defined as having a “relapse”
when seizures were controlled for more than 12 consecu-
tive months and reoccurred thereafter. At the end of the
two years follow-up period, patients were considered to
be in “remission” if they had not had seizures of any
type for a minimum of one year while receiving appro-
priate antiepileptic drug treatment. At the end of the
four years’ follow-up, they were considered to be in
“long-term remission” if they had reported no seizures
for a minimum of two years. “Terminal remission” was
defined as being seizure free for a minimum of 2 years
preceding the end of follow-up. For those subjects who
were followed prospectively the end of follow-up was
considered to be the time of their last visit, whereas for
those observed retrospectively the time of their reevalua-
tion by December 2012. Patients who were never seizure
free for a whole year were considered to be “drug-resistant”.
All definitions were applied to patients following an
appropriate antiepileptic drug treatment at the proper
daily doses.
As far as the clinical course of the idiopathic epilepsy
is concerned, patients were classified into four mutually
exclusive patterns of clinical course, following the meth-
odology used in a previous study of both children and
adults with newly diagnosed epilepsy by Brodie, Kwan
and associates [7]. In pattern A, defined as “excellent”
clinical course, children became seizure free early and
remained so throughout follow-up. In pattern B, seizure
freedom was delayed for more than 12 months after
starting treatment but patients remained seizure free
throughout their follow up and thus this clinical course
was defined as “improving”. Patients with pattern C were
considered as having a “relapsing” clinical course, with
periods of seizure freedom lasting more than one year
interspersed with relapses. Finally, patients exhibiting
pattern D, defined as “poor” clinical course, were “drug-
resistant” throughout follow-up, as explained above.
Variables and investigations
A priori defined variables based on individual and clin-
ical characteristics of each patient, “seizure” history,
EEG and neuroimaging findings, as well as history of
coexisting migraine or sleep disorders were collected at
intake and after 12 months of treatment. Status epilepticus
was defined as continuous seizure activity or not regaining
consciousness between seizures for at least 30 minutes [8].
Academic performance was evaluated on the basis of
family and teachers’ information and no objective screen-
ing tool was applied to the subjects of the present study. Itwas considered “excellent” when children received high
grades in school, “good” when they followed lessons
without any difficulty, “average” when they encountered
minor difficulties and “poor” when they had significant
difficulty or learning disorders. All children had a standard
electroencephalogram (EEG). In children without epilepti-
form abnormalities, a second EEG was performed after
partial sleep deprivation. Neuroimaging was performed
with magnetic resonance imaging (MRI) or computed
tomography (CT) when the treating physician considered
it reevaluated at the end of the study follow-up, by
December 31, 2012 necessary.Statistical analyses
Data were analyzed using the IBM SPSS for Windows
v.20 software (IBM, New York, USA). Numerical variables
were presented as mean (±SD) except for non-normal dis-
tributed variables, where the median, interquartile range
(IQR), and range was calculated. Kolmogorov-Smirnov
test was used to evaluate whether each variable followed a
Gaussian distribution. Categorical variables were summa-
rized using frequencies and percentages. The relationships
among study variables were investigated using Pearson
product–moment correlation coefficient (r), whereas
correlations including at least one non-normal variable
were performed using Spearman correlation coefficient
(rho). Categorical variable association was assessed using
chi-square test or Fisher’s exact test when appropriate. We
used binary logistic regression to study the predictors of
terminal remission. Multivariate logistic regression was
used to evaluate the combined effect of the strongest pre-
dictors regarding early, two year and long term outcome.
Model calibration was evaluated using the Hosmer-
Lemeshow goodness-of-fit test. In the univariate analysis
preceding the multivariate, potential prognostic factors
were assessed using P-value <0.05 as a cut-off criterion.
In the multivariate analysis backward elimination step-
wise procedure was used, where variables having p-value
greater than 0.10 were removed from the models. The
probability curves of terminal remission were obtained
according to the Kaplan-Meier method and compared by
the log-rank test.Results
A total of 303 children and adolescents (N = 160, 52,8%
male, N = 143, 47,2% female), diagnosed with epilepsy
of idiopathic etiology were included in the study. The
mean age at onset of epilepsy was 6,7 years (median 6,5,
range 1,0-14,0, std. dev. 3,0) and the mean duration of
follow-up was 8,3 years (median 7,0, range 2,0-22,0, std.
dev. 4,24). In 255 of 303 subjects a specific idiopathic
epileptic syndrome was recognized, while in the remaining
48 (15,8%) epilepsy was considered as being idiopathic
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10,2%) or idiopathic otherwise unclassified (N = 3, 1,0%).
Table 1 summarizes the clinical features of the study
population. 18,5% of the children and adolescents with
idiopathic epilepsy (N = 56/303) had a history of febrile
seizures, 21,2% (N = 64/303) a positive family history of
epilepsy and 16,2% (N = 49/303) a history of concomi-
tant migraine disorder. 8,3% of the subjects (N = 25/303)
were documented as having sleep disorders. Regarding
their academic performance, the majority of children
(61,7%) accomplished all school requirements without
any difficulty (“good” academic performance), 6,3% (N =
19) had an “excellent” performance, 21,5% (N = 65) en-
countered mild difficulties in the learning procedure
(“average” academic performance) and 10.6% (N = 32)
exhibited a “poor” academic performance with signifi-
cant learning disorders. Regarding their seizure activity,
12,5% of the children (N = 38) manifested more than
one seizure types and only 3,3% (N = 10) were docu-
mented as having had status epilepticus. EEG findings
were normal in 9,6% of the patients, focal in 50,8%, gen-
eralized in 44,2%, while in 4% (N = 12) of the children
background activity exhibited generalized slowing. Neu-
roimaging studies were performed in 216 children and
adolescents, with normal findings in 206 (95,4%) of the
cases. Minor abnormalities, not causally correlated with
seizures and epilepsy, were reported in 10 of the cases
(3,3%).
Early response to treatment
During the initial 12 months of follow-up, “early remis-
sion” was observed in 213 patients (70,3%) of the cohort,
while the remaining 90 patients (29,7%) exhibited seizure
activity beyond the initial 3 months of follow-up. 53 pa-
tients (17,5%) had less than 3 epileptic episodes, 27 pa-
tients (8,9%) more than 3 but less than 6 episodes and
only 10 patients (3,3%) had frequent seizures (>6 epi-
sodes/year).
Final outcome (outcome at last follow-up)
At the end of the study, a total of 292 subjects (96,3%)
were in terminal remission (N = 251, 82,8% off AEDs,
N = 41, 13,5% on AEDs). Epilepsy was still active in the
remaining 11 subjects (3,7%), 6 of whom were intractable,
with no remission exceeding 12 months during follow-up,
and 5 were in relapse at the end of follow-up. Table 2
summarizes the clinical course and outcome of each epi-
lepsy syndrome and Figure 1 shows the patients’ flow
throughout the study in terms of seizure outcome.
AED treatment
Among the group of patients who achieved terminal re-
mission, a total of 244 (83,6%) remained seizure-free on
their first AED, while 36 (12,3%) were treated with asecond AED, as monotherapy or in combination with
the first drug. Only 11 patients (3,7%) with idiopathic
epilepsy attained seizure freedom receiving 3 AEDs and
1 (0,4%) requiring >3 AEDs.
Epileptic syndrome
The two most frequently encountered idiopathic epi-
leptic syndromes in our study were benign childhood
epilepsy with centrotemporal spikes (BCECTS) and child-
hood absence epilepsy (CAE). 107 patients (35,3%) were
diagnosed with BCECTS, the ratio of boys to girls exceed-
ing 3/2, with a mean age at seizure onset of approximately
7 years (peak at 4 years for boys and 8 years for girls).
CAE was diagnosed in 80 patients (26,4%) of the cohort,
mostly girls, with a ratio of 3/2 versus boys, and a mean
age at seizure onset of 6,4 years for boys and 5,9 for girls
(peak at 4 years for both sexes). Statistical analysis of their
clinical characteristics and prognosis demonstrated the
following: (a) regarding clinical characteristics, there was a
higher incidence of poor – average academic performance
documented in children with CAE as opposed to chil-
dren with rolandic epilepsy (p = 0,011), (b) regarding
clinical course and seizure outcome, there was no not-
able difference in the early response to treatment,
long-term outcome, final outcome and clinical course
of epilepsy between the two syndromes, however the
short-term outcome after 2 years of follow-up was sig-
nificantly more favorable (p = 0,01) in children with
absence epilepsy as opposed to those treated for rolan-
dic epilepsy.
Regarding the prognosis of idiopathic epileptic syn-
dromes other than CAE and BCECTS, as presented in
Table 2, all patients with Panayiotopoulos syndrome
(N = 5/5) and Benign epilepsy in infancy (N = 2/2)
achieved terminal remission following a benign non-
relapsing clinical course. Both patients diagnosed with
Gastaut type occipital epilepsy and Myoclonic epilepsy in
infancy also achieved seizure control at final follow-up,
but one or more relapses were noted in the course of epi-
lepsy of single subjects. Patients with Juvenile myoclonic
epilepsy exhibited the highest rate of a relapsing course
(80%), followed by Epilepsy with myoclonic absences
(60%) and Photosensitive-reflex epilepsy (50%). Finally, the
highest rate of drug-resistance was found among children
diagnosed with Epilepsy with myoclonic-astatic seizures
(12,5%) and Idiopathic partial epilepsy otherwise not clas-
sified (12,9%).
Course during follow-up
An “excellent” clinical course, or pattern A, was ob-
served in 161 children and adolescents with idiopathic
epilepsy (53,1%), who became seizure-free immediately
and remained so for the remainder of the follow-up.
Among these 161 patients, 157 (97,5%) received 1 AED





Age at seizure onset
1-4 years 86 28,4
>4-6 years 65 21,5
>6-9 years 89 29,4
>9-12 years 55 18,2
>12 years old 8 2,6
History of febrile seizures
No 247 81,5
Yes 56 18,5














Time elapsed between seizure onset and
treatment with AEDs
No time 81 26,7
6 months 170 56,1
6-12 months 19 6,3
>1 year 33 10,9
Number of episodes before onset of treatment
1-2 episodes 118 38,9
3-5 episodes 81 26,7
>5 episodes 104 34,3
Number of seizure types
One 265 87,5








Abnormal background activity 12 4,0
Focal discharges 154 50,8




Not conducted 87 28,7
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subjects with outcome pattern A required 3 or more
AEDs during follow-up.
Outcome pattern B, considered to represent an “im-
proving” clinical course, was identified in 69 patients
(22,8%), who continued to report seizures during the first
12 months of treatment, but later became and remained
seizure-free until the end of follow-up. More than half of
these patients (N = 39, 56,5%) achieved seizure freedom
treated with their first AED, 22 (31,9%) required a second
AED and 8 (11,6%) required a third one.
A total of 67 patients (22,1%) demonstrated a more
fluctuating course (outcome pattern C). After attaining a
seizure-free period of a year or more, they were re-
ported to have a relapse, either being on AEDs or after
discontinuation of treatment. 51 out of 67 (76%) sub-
jects following a remitting-relapsing course received 1
AED, 12 patients (18%) received 2 and 4 (5%) required
treatment with 3 or more AEDs.
Only 6 children and adolescents with idiopathic epilepsy
(2%) never became seizure-free for any complete year
throughout follow-up (pattern D), representing the sub-
group of patient population with a “poor” clinical course.
Among these 6 patients, 3 received 2 regimens, 1 received
3 and the remaining 2 were treated with more than 3
AEDs.
Proportion of seizure remission during follow-up
Figure 2 shows the proportion of subjects reaching
terminal remission during the years of follow-up. As
demonstrated, after 2 years of follow-up almost 80% of
children with idiopathic epilepsy have the chance to
achieve remission of seizures. After 4, 6, 8 and 10 years
of follow-up, the chance of remission reaches 90%,
96%, 98% and 99% of the patients.
Predictive variables
The determinants of early and long-term seizure outcome
and clinical course of idiopathic childhood epilepsy after
multivariate analysis are summarized in Table 3. An












N N (%) N (%) N (%) N (%) N (%) N (%)
Benign childhood epilepsy with centrotemporal spikes 107 107 (100,0) 0 61 (57,0) 22 (20,5) 24 (22,5) 0
Early onset benign occipital epilepsy (Panayiotopoulos type) 5 5 (100,0) 0 2 (40,0) 3 (60,0) 0 0
Late onset occipital epilepsy (Gastaut type) 2 2 (100,0) 0 1 (50,0) 0 1 (50,0) 0
Benign epilepsy of infancy 2 2 (100,0) 0 1 (50,0) 1 (50,0) 0 0
Myoclonic epilepsy in infancy 3 3 (100,0) 0 1 (33,3) 1 (33,3) 1 (33,3) 0
Childhood absence epilepsy 80 70 (98,7) 1 (1,3) 53 (66,2) 15 (18,8) 11 (13,7) 1 (1,3)
Juvenile absence epilepsy 5 5 (100,0) 0 4 (80,0) 0 1 (20,0) 0
Juvenile myoclonic epilepsy 5 4 (80,0) 1 (20,0) 1 (20,0) 0 4 (80,0) 0
Epilepsy with GTCS only 16 16 (100,0) 0 9 (56,3) 3 (18,7) 4 (25,0) 0
Generalized epilepsies with febrile seizures + 9 9 (100,0) 0 5 (55,6) 0 4 (44,4) 0
Epilepsy with myoclonic-astatic seizures 8 7 (87,5) 1 (12,5) 0 6 (75,0) 1 (12,5) 1 (12,5)
Epilepsy with myoclonic absences 5 5 (100,0) 0 0 2 (40,0) 3 (60,0) 0
Idiopathic partial epilepsy 31 26 (83,8) 5 (16,2) 11 (35,5) 11 (35,5) 5 (16,1) 4 (12,9)
Idiopathic generalized epilepsy 14 13 (92,8) 1 (7,2) 9 (64,3) 3 (21,4) 2 (14,2) 0
Photosensitive-reflex epilepsy 8 7 (87,5) 1 (12,5) 3 (37,5) 1 (12,5) 4 (50,0) 0
Idiopathic unclassified 3 2 (66,7) 1 (33,3) 0 1 (33,3) 2 (66,7) 0
Total 303 292 (96,3) 11 (3,7) 161 (53,1) 69 (22,8) 67 (22,1) 6 (2,0)
Newly diagnosed epilepsy
Ν= 303
Immediate response to treatment
Ν= 213


































Figure 1 Patient flow throughout the study in terms of seizure outcome. Terminal remission: seizure-freedom of at least 2 years preceding
the end of follow-up. Pattern A (early and sustained seizure freedom): patients became seizure-free within 12 months of starting treatment and
remained seizure-free. Pattern B (delayed and sustained seizure freedom): patients became seizure-free after 12 months of starting treatment and
remained seizure-free. Pattern C (fluctuating course): patients fluctuating between periods of seizure freedom and relapse. Pattern D: patients
never seizure-free for any complete year.
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Figure 2 Kaplan-Meier curve indicating the cumulative proportion of study subjects reaching terminal remission during follow-up.
Terminal remission: seizure-freedom of at least 2 years.
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vides the results of the univariate analysis [see Additional
file 1]. After both univariate and multivariate analysis,
younger age at seizure onset was strongly associated
with initial non-response to treatment (p = 0,003) and a
“relapsing“ course of epilepsy (p = 0,004), whereas it
didn’t appear to determine final seizure outcome at the
end of follow-up. The same relevance applied to the oc-
currence of status epilepticus (p = 0,045) and positive
history of febrile seizures (p = 0,008) after univariate
analysis, but their statistical relevance subsided after
multivariate analysis. On the other hand, the presence
of multiple seizure types and history of migraine were
strongly associated with an unfavorable prognosis both
after univariate and multivariate analysis. Multiple seizure
types were prognostic of a poorer outcome during the
initial year of treatment (p = 0,000), and a “relapsing”
overall clinical course (p = 0,004). History or migraine
was associated with a decreased chance of remission after
long-term follow-up (p = 0,002), as well as at the end of
follow-up (p = 0,0,14) and furthermore associated with an
increased chance of a “relapsing” clinical course (p = 0,03).
The most important predictive factor of the clinical
course and final outcome of idiopathic epilepsy after multi-
variate analysis was the initial response to antiepileptic
treatment. Early response to treatment was strongly corre-
lated with remission after short-term follow-up (p = 0,000)with a decreased chance of following a relapsing course
(p = 0,013). Children with initial non response to treat-
ment carried a 10-fold higher risk of not reaching
terminal remission at the end of follow-up (p = 0,004,
OR = 10,95).
Figure 3 demonstrates the effect of initial response to
treatment to the cumulative proportion of patients reach-
ing a 6-month remission during follow-up. As demon-
strated, after 2 years of follow-up the patients who were
seizure-free during the initial year of treatment had >80%
chance of being in remission, whereas the patients who
exhibited seizure activity a chance of approximately 67%.
After 4 years of follow-up, the chances were estimated at
92% and 86% accordingly for each of the two groups.Discussion
Idiopathic epilepsies and epileptic syndromes predom-
inate childhood and adolescence epilepsy. They are age-
dependent epilepsies of presumably genetic origin with an
overall favorable prognosis with regard to seizure control.
The aim of the present study was to observe and describe
a large population of children and adolescents with idio-
pathic epilepsy over time in order to report the clinical
course and prognosis of each epileptic syndrome and to
identify variables prognostic of a less than favorable out-
come after short-term and long-term follow-up.
Table 3 Multivariate analysis of prognostic factors
Prognostic factors p-value OR 95% CI
Early response to treatment – occurrence of seizures in the initial 12 months
Associated with an increased chance of seizure occurrence
Multiple seizure types 0,000 3,905 1,897-8,035
Status epilepticus 0,051 3,769 0,997-14,249
Associated with a decreased chance of seizure occurrence
Age at seizure onset 0,003 0,707 0,561-0,889
Outcome at 2 years of follow-up – remission of seizures
Associated with an increased chance of remission
Epileptic syndrome (CAE) 0,009 3,174 1,329-7,579
Early response to treatment 0,000 3,291 1,795-6,034
Outcome at 4 years of follow-up – occurrence of seizures in the preceding two years
Associated with an increased chance of seizure occurrence
History of febrile seizures 0,011 2,788 1,271-6,116
History of migraine 0,002 3,446 1,571-7,559
Associated with a decreased chance of seizure occurrence
Academic performance 0,056 0,651 0,419-1,010
Final outcome at the end of follow-up – occurrence of seizures in the preceding two years
Associated with an increased chance of seizure occurrence
History of migraine 0,014 5,305 1,393-20,193
Multiple seizure types 0,069 3,413 0,911-12,789
Initial non response to treatment 0,004 10,95 2,18-54,99
Clinical course – relapsing pattern C
Associated with an increased chance of pattern C-“relapsing” clinical course
Multiple seizure types 0,004 3,308 1,449-7,547
History of migraine 0,03 2,309 1,083-4,922
Associated with a decreased chance of pattern C -“relapsing” clinical course
Early response to treatment 0,013 0,395 0,191-0,820
Age at seizure onset 0,004 0,671 0,511-0,879
OR (odds ratio).
CAE (childhood absence epilepsy).
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the prognosis of childhood epilepsy has been addressed in
various studies following large cohorts of children, both
retrospectively and prospectively, the duration of follow-
up ranging from months to 37 years [9-15]. The majority
of these studies concern children with both idiopathic and
non-idiopathic epilepsies and conclude that the long-term
outcome in childhood-onset epilepsy is favorable in about
two-thirds of children [15]. However, when epilepsies of
solely idiopathic etiology are concerned, the remission
rate is considerably higher [13], reaching nearly 100%
for benign childhood epilepsy with centrotemporal spikes
by midadolescence [16].
In our study, after observing and analyzing the clinical
course of a relatively large cohort of children and adoles-
cents with idiopathic epileptic syndromes, the vast majorityof the children had a favorable outcome at last contact,
70% of the children became immediately seizure free and
after two years of follow-up the rate of remission was al-
most 80%. In the Dutch Study of Epilepsy in Childhood,
69% of 466 children with epilepsy were in remission after
2 years of follow-up and 71% were in long-term remission
after 15 years. When referring to epileptic syndromes of
idiopathic etiology, the rate of remission after 2 years of
follow-up was 78% (184/235) and the rate of a 5 years
terminal remission at last follow-up was 86% [15,17,18].
The lower percentage of terminal remission in the
Dutch study possibly reflects the lower number of chil-
dren with benign rolandic epilepsy included in the study
population (23/210) as compared to the present study
(107/303), given the excellent prognosis of the syndrome.
In the Finish population-based study of 144 children with
Figure 3 Kaplan-Meier curve indicating the cumulative proportion of study subjects reaching 6-month remission during follow-up
according to initial response to treatment. The green line represents the patients who were seizure-free during the initial year of treatment,
the yellow line the patients who experienced seizure activity and the blue line represents the total of all patients.
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reported a five years terminal remission of 67% for both
idiopathic and symptomatic epilepsies with childhood
onset, which rose to 89% regarding idiopathic epilepsies,
however the prognosis of specific idiopathic epileptic
syndromes was not addressed [10,13].
Given the overall favorable outcome of idiopathic child-
hood epilepsy concluded by the available literature, the
focus of research is aimed at studying the clinical course
over time in order to identify determinants of early and
permanent seizure control (“smooth sailing” epilepsy,
[11]) as opposed to following a remitting-relapsing clinical
course, as well as determinants of exhibiting a less than
favorable outcome in certain epileptic syndromes and
groups of patients.
In the present study, concerning children with idio-
pathic epilepsy, that is epilepsy only, without any under-
lying etiology or major comorbidities, more than half of
the children had an “excellent” clinical course, with imme-
diate response to treatment that was sustained until the
end of follow-up, while an additional 23% of the cohort
exhibited a delayed response, after at least 12 months of
treatment, but remained seizure-free throughout follow-
up. Reviewing the patterns of treatment response in newlydiagnosed epilepsy studied by Brodie, Kwan and associates
in a vast population of adult patients and children older
than 9 years old with epilepsy, “excellent” clinical course
was documented in considerably fewer patients, that is
37% of the cohort, and drug-resistance in considerably
more than the present study, that is 25% as opposed to
2% [7]. These differences confirm the presence a more
favorable clinical course demonstrated in childhood and
epilepsies of idiopathic etiology.
Regarding the rate of a “remitting-relapsing” course in
childhood epilepsy, our findings are comparable with the
results of the prospective study measuring remission and
relapse in children with epilepsy conducted by Berg,
Shinnar and colleagues [14]. After achieving a 2-year re-
mission, 107 out of 442 children of their cohort (24,2%)
experienced a relapse and the risk of relapse varied by epi-
leptic syndrome, with juvenile myoclonic epilepsy carrying
a very high risk and idiopathic partial epilepsy a very low
risk. Accordingly, in our study, the highest rates of relapse
were exhibited in children with juvenile myoclonic epi-
lepsy and epilepsy with myoclonic absences. However,
when comparing the most frequent epileptic syndromes of
idiopathic partial and generalized epilepsy, that is rolandic
and childhood absence epilepsy, our findings demonstrate
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rolandic epilepsy (22,5%) than children with CAE (13,7%),
both reattaining remission after long-term follow-up. Fur-
ther analysis of our study population results reveals that
children diagnosed with BCECTS at a pre-school age had
an increased risk of following a relapsing clinical course,
without affecting their chances of terminal remission, as
seen also in the study by You, Kim and Ko of Seoul, South
Korea [19].
Overall comparison of the clinical characteristics and
clinical course of BCECTS and CAE confirmed the use
of the term “benign”, commonly assigned to both epilep-
tic syndromes, as far as seizure control is concerned.
Early response to treatment during the initial 12 months
and final outcome were equally favorable among chil-
dren with either epileptic syndrome, however after two
years of follow-up, more children with CAE exhibited a
terminal remission compared to children with BCECTS.
Our findings are in agreement with those reported by
Berg and associates, who found that after two years of
follow-up, the highest rate of remission was exhibited by
children who were documented to have typical absence
seizures as compared to any other seizure type [14]. How-
ever, in terms of academic performance and cognitive out-
come, a less favorable prognosis of CAE was documented
in our study, in accordance with what is known from
review of the current literature [20-22].
Regarding other epileptic syndromes, in the present
study we encountered an invariably favorable progno-
sis among children with Panayiotopoulos syndrome, a
high relapsing rate among patients with juvenile myo-
clonic epilepsy, epilepsy with myoclonic absences and
photosensitive-reflex epilepsies and a considerable rate
of drug resistance among children with myoclonic astatic
epilepsy and idiopathic partial epilepsy not otherwise clas-
sified. However, the small number of patients allocated to
each separate epileptic syndrome would not allow for safe
conclusions to be drawn on their overall prognosis.
As far as predictive variables of idiopathic childhood
epilepsy are concerned, multivariate analysis revealed that
multiple seizure types, occurrence of status epilepticus and
young age at seizure onset were significantly associated
with a poorer initial response to treatment, while age at
seizure onset between 6–9 years old was associated with
an increased chance of early remission. At the end of
follow-up, the single most important prognostic factor
was early response to treatment during the first 12 months,
which was highly predictive of a terminal remission at
the end of follow-up. On the contrary, a positive history
of migraine and the presence of multiple seizures were
associated with a less favorable final outcome.
Very young age at seizure onset was found to be associ-
ated with a poorer prognosis in various studies of child-
hood epilepsy prognosis [9,12,18,23] and this finding canbe attributed mostly to the higher prevalence of symptom-
atic and cryptogenic epilepsies in children during the first
year of life. When focusing on idiopathic epilepsies, the
distribution of specific benign epileptic syndromes at
certain ages, for instance occurrence of idiopathic par-
tial epilepsy between 6–12 years old, possibly explains
the favorable prognosis experienced by children of this
age group. Furthermore, even within the same epileptic
syndrome, for instance BCECTS, younger age at seizure
onset is found to be predictive of a poorer initial re-
sponse to treatment [16,19,24].
The most significant determinant of seizure outcome
in idiopathic childhood epilepsy revealed by the present
study was the initial response to treatment during the first
12 months. The significance of early response to treatment
as a prognostic factor was highlighted in various prognos-
tic studies. Sillanpaa, Shinnar and colleagues reported at
the New England Journal of Medicine in 1998 that the sin-
gle best predictor of remission both in their overall cohort
and in the subgroups classified according to etiology was
an early response to drug therapy [13], while Geerts, Arts
and associates, conducting the Dutch study of epilepsy
in childhood, concluded that after long-term follow-
up, epilepsy remained active or intractable often after
having an early unfavorable course or non-idiopathic
etiology [15].
Two separate clinical characteristics that were revealed
in the present study as determinants of seizure outcome
were the presence of multiple seizure types and the positive
history of migraine. Regarding seizure types, it was shown
that the occurrence of more than one seizure type was
associated with a poorer initial response to treatment,
as well as a less than favorable final outcome and a
higher chance of a fluctuating course of epilepsy. These
findings can be attributed to the coexistence of multiple
seizure types in certain epileptic syndromes that exhib-
ited a higher rate of drug-resistance or relapsing course,
as for instance epilepsy with myoclonic-astatic seizures
or epilepsy with myoclonic absence seizures. Further-
more, as reported in previous studies, the occurrence of
generalized tonic-clonic seizures in addition to absence
or myoclonic seizures is considered to be predictive of a
less than favorable outcome in idiopathic generalized
epilepsies of childhood and adolescence [25].
The prognostic significance of migraine disorder as a
comorbidity of childhood idiopathic epilepsy has not been
previously reported, as to our knowledge. While there is a
vast literature reporting the similar molecular and genetic
basis of the two conditions, both considered as disorders
that lie in the spectrum of channelopathies [25-28], the
impact of migraine on the clinical course and outcome
of epilepsy has only been documented sparsely in adult
epilepsy. In one prospective study published in 2005 at
Cephalalgia, 59 adults with epilepsy and migraine were
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with epilepsy only and the authors concluded that the
positive history of migraine disorder was associated
with a decreased chance of immediate response to anti-
epileptic therapy, a less than favorable clinical course
and a decreased chance of achieving terminal remission,
especially during the last two years of the follow-up
[29]. Further study is needed in order to support the
negative impact of migraine disorder on the outcome of
idiopathic epilepsy in childhood.Advantages and limitations
The size of the cohort and the length of follow-up
regarding exclusively children with idiopathic epileptic
syndromes are advantages of the present study. Not
many cohorts are comparable on these points. The main
limitation of this study is the fact that the course of epi-
lepsy in the majority of subjects was followed retrospect-
ively based on hospital records, a fact that initially makes
proper syndromic diagnosis challenging. However, the ex-
istence of detailed clinical and EEG documentation for all
retrospective subjects included in the study allowed for a
syndromic classification to be safely reached in the major-
ity of cases. Moreover, all patients were reevaluated at the
end of the long-term follow-up and their clinical course
and seizure outcome was accurately recorded.Conclusions
The long-term prognosis of idiopathic epilepsy in child-
hood is favorable in the vast majority of children. In terms
of seizure control, the two most frequently encountered
idiopathic epileptic syndromes, benign childhood epi-
lepsy with centrotemporal spikes and childhood absence
epilepsy, exhibit an excellent prognosis and can be consid-
ered as “benign”. During follow-up, the course of idio-
pathic childhood epilepsy is characterized by the presence
of relapses in 22% of the children; however the vast major-
ity achieve remission at the end of long-term follow-up.
Predictors of a “smooth-sailing” clinical course were shown
to be early response to antiepileptic drug therapy, as well
as age at seizure onset between 6–9 years old. On the con-
trary, clinical variables such as multiple seizure types,
young age at seizure onset and history of migraine were
associated with a poorer prognosis.Ethical committee approval
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